Applied Molecular Transport Inc. Common Stock
AMTI
AMTI was delisted on the 26th of December, 2023.
43 hedge funds and large institutions have $7.85M invested in Applied Molecular Transport Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 9 increasing their positions, 19 reducing their positions, and 10 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
11.53% less ownership
Funds ownership: 59.53% → 48% (-12%)
12% less funds holding
Funds holding: 49 → 43 (-6)
53% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 19
60% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 10
66% less capital invested
Capital invested by funds: $23M → $7.85M (-$15.2M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FFVM
Founders Fund VI Management
San Francisco,
California
|
+$503K |
| 2 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$269K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$69K |
| 4 |
Millennium Management
New York
|
+$47.9K |
| 5 |
IC
IEQ Capital
Foster City,
California
|
+$25.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
-$1.81M |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$1.29M |
| 3 |
Morgan Stanley
New York
|
-$400K |
| 4 |
PHAM
Pacific Heights Asset Management
San Francisco,
California
|
-$311K |
| 5 |
ECG
EPIQ Capital Group
San Francisco,
California
|
-$302K |
AMTI Hedge Fund Activity: Q4 2022 in Review
43 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in Applied Molecular Transport Inc. Common Stock (AMTI) for Q4 2022, worth a combined $7.85M — down 66% from $23M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of AMTI and 4 opened new positions — a net loss of 6 holders — while 19 trimmed existing stakes and 9 added.
The largest buyer was Founders Fund VI Management, adding an estimated $503K. The largest seller was Capital World Investors, exiting entirely with an estimated $1.81M sold.
- 43 institutional investors held Applied Molecular Transport Inc. Common Stock (AMTI) as of Q4 2022, down from 49 in Q3 2022.
- Funds reported $7.85M of Applied Molecular Transport Inc. Common Stock stock for Q4 2022, down 66% quarter-over-quarter.
- 4 funds opened new Applied Molecular Transport Inc. Common Stock positions in Q4 2022 and 10 closed out, a net change of -6 holders.
- The largest Applied Molecular Transport Inc. Common Stock buyer in Q4 2022 was Founders Fund VI Management, an estimated $503K added.
- The largest Applied Molecular Transport Inc. Common Stock seller in Q4 2022 was Capital World Investors, an estimated $1.81M sold.
Based on aggregated 13F filings for Q4 2022.